EMEA-002311-PIP01-17-M02
Key facts
| Invented name |
Trogarzo
|
| Active substance |
Ibalizumab
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0248/2021
|
| PIP number |
EMEA-002311-PIP01-17-M02
|
| Pharmaceutical form(s) |
Concentrate for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Theratechnologies International Limited
Tel. +1 5143367800 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|